Skip to navigation

Press Releases

MS TSX: Quote: 3.45 | Change: -0.15 | 01.05.09 | 14:27:00 MST

2006 Press Releases

Date       Title
December 7, 2006       BioMS Pivotal Multiple Sclerosis Trial Receives Sixth Positive Review
December 4, 2006       BioMS Medical Raises Additional $6.2 Million in Private Placement
November 24, 2006       BioMS Medical Corp Announces Private Placement
November 23, 2006       BioMS Commences Enrolment in a Relapsing Remitting Multiple Sclerosis Trial
November 16, 2006       BioMS Announces Professor Hartung As Coordinator in Germany for Pivotal MS Trial
November 13, 2006       BioMS Medical Announces Third Quarter 2006 Results
November 3, 2006       BioMS to Present at the MS Society, Alberta AGM and Rodman & Renshaw Conference
November 2, 2006       BioMS Receives Additional Patent for Multiple Sclerosis Drug MBP8298 in the US
October 24, 2006       BioMS Medical Expands Pivotal Multiple Sclerosis Trial Into the Baltic States
October 12, 2006       BioMS Medical Expands Pivotal Multiple Sclerosis Trial Into Finland
October 3, 2006       BioMS Medical to Present at Sachs Associates’ Investor Forum and BioContact 2006
September 22, 2006       BioMS Medical Announces Appointment to Board of Directors
August 16, 2006       BioMS Pivotal Multiple Sclerosis Trial Receives Fifth Positive Review
August 14, 2006       BioMS Medical Announces Second Quarter 2006 Results
August 11, 2006       BioMS Announces its Intention to Renew a Normal Course Issuer Bid
June 22, 2006       BioMS Medical Expands Pivotal Multiple Sclerosis Trial Into the Netherlands
June 13, 2006       European Journal of Neurology Publishes MBP8298 Long-term Follow-up Data
June 2, 2006       BioMS Medical to Present at Federation of Clinical Immunology Societies 2006
June 1, 2006       BioMS Medical Completes $15 Million Private Placement
May 26, 2006       BioMS Medical Announces Private Placement
May 16, 2006       BioMS Medical Announces First Quarter 2006 Results
May 16, 2006       BioMS Receives Approval for Phase II Relapsing-Remitting Multiple Sclerosis Trial
May 12, 2006       BioMS to Present at the Rodman & Renshaw 3rd Annual Global Healthcare Conference
May 10, 2006       BioMS Medical Expands Pivotal Multiple Sclerosis Trial Into Denmark
May 9, 2006       BioMS Medical Reaches Milestone in Pivotal Multiple Sclerosis Trial
May 3, 2006       BioMS Medical’s Pivotal Multiple Sclerosis Trial Receives Fourth Positive Review
April 28, 2006       BioMS Medical to Present at BioFinance 2006
April 26, 2006       BioMS to Present Clinical and Manufacturing Information at TIDES Conference 2006
March 28, 2006       BioMS Medical Announces Change of Auditor
March 13, 2006       BioMS Plans Relapsing-Remitting Multiple Sclerosis Trial
March 10, 2006       BioMS Medical to Present at the Sachs Associates 5th Annual North America Forum
March 7, 2006       BioMS MBP8298 Shows Delay of Progression in Patients with Multiple Sclerosis
February 17, 2006       BioMS Medical Announces 2005 Year-End Results
February 15, 2006       BioMS Secures Long-Term Manufacturing Agreements for Multiple Sclerosis Drug
February 9, 2006       BioMS Medical to Present at BIO CEO & Investor Conference
February 7, 2006       BioMS Pivotal Multiple Sclerosis Trial Receives Third Positive Review
January 26, 2006       BioMS Medical Retains Icon for Pivotal Multiple Sclerosis Trial
January 25, 2006       BioMS Medical to Present at Brean Murray Institutional Investor Conference
January 19, 2006       BioMS Medical CEO Receives BioAlberta Award for Entrepreneurship
January 6, 2006       BioMS Medical Increases Equity Position in Drug Delivery Company

BioMS News